IM Cannabis (IMCC) Interest Coverage Ratio Growth (3y) (2023 - 2026)
IM Cannabis (IMCC) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 4.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.28% |
| Mar 31, 2026 | -30.80% |
| Dec 31, 2025 | -29.87% |
| Sep 30, 2025 | 95.01% |
| Jun 30, 2025 | -57.30% |
| Mar 31, 2025 | -57.75% |
| Dec 31, 2024 | 85.33% |
| Sep 30, 2024 | 33.07% |
| Jun 30, 2024 | 28.05% |
| Mar 31, 2024 | -20.22% |
| Dec 31, 2023 | 160.95% |
| Sep 30, 2023 | -54.41% |
| Jun 30, 2023 | 45.29% |
| Mar 31, 2023 | -62.02% |